Kubota Pharmaceutical Holdings Co., Ltd.
  • HOME
  • PIPELINE
  • IR LIBRARY
  •  
  • PUBLICATIONS
  • COMPANY
  • NEWS
Kubota Pharmaceutical Holdings Co., Ltd.
日本語
  • PIPELINE
  • IR LIBRARY
  • PUBLICATIONS
  •  
  • COMPANY

IR LIBRARY

News & Press Releases

08/12 IR
Notice Concerning Issuance of the 28th Stock Acquisition Rights (with Exercise Price Revision Clauses) by Third-Party Allotment and Execution of Third-Party Allotment Agreement (in Japanese)
08/12 IR
Quarterly Report for the second quarter of FY2022 (in Japanese)
08/12 IR
Consolidated Financial Results for the Six Months Ended June 30, 2022 (under IFRS)
08/12 IR
Notice Concerning Change in Use of Funds for the 25th Stock Acquisition Rights (with Exercise Price Revision Clauses) (in Japanese)
more info
For information on SEC filings, please visit U.S. SEC's EDGAR service.
CEO Message

Company Financials

  • SEC Filings
  • Shareholders Meeting
  • IR News
  • Corporate Governance
  • Financial Events Calendar
  • FAQs
  • Email Alerts
Kubota Pharmaceutical Holdings Co., Ltd.
PIPELINE
IR LIBRARY
  • News & PR
  • SEC Filings
  • CEO Message
  • Company Financials
  • Corporate Governance
  • IR News
  • Financial Events Calendar
  • FAQs
  • Email Alerts
 
PUBLICATIONS
COMPANY
  • Corporate Information
  • Management
  • Corporate History
Kubota Pharmaceutical Holdings Co., Ltd.
  • Contact Us
  • Privacy Policy
  • Terms of Use
© 2020 Kubota Pharmaceutical Holdings Co., Ltd.